The Great Lakes IT Reports says that the Van Andel Institute and Spectrum Health in Grand Rapids have formed a new joint venture, the Center for Molecular Medicine. The Center will offer molecular technologies for investigation of complex diseases like cancer, heart disease, mental illness and other conditions at the DNA, RNA and protein levels.
Daniel H. Farkas, Ph.D., a nationally respected leader in the field of molecular diagnostics, has been named Executive Director of the CMM. Richard C. Breon, President & CEO, Spectrum Health said:
“The Center for Molecular Medicine is an investment in the future of health care. It accelerates the drive toward personalized medicine â€“ the tailoring of treatment based on molecular make-up. We are very fortunate to have an individual of Dan Farkas’ caliber on board as we work to offer physicians and their patients the most advanced diagnostic treatment options available – options typically offered only at the nation’s largest academic medical research centers.”